Fact CheckerSign in

NCT05252884Completed

Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial

Comparison of Routine Prophylactic Calcium + Calcitriol and Selective Use Based on PTH for the Prevention of Postoperative Hypocalcemia in Patients With Total Thyroidectomy. Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 7 Feb 2025

Brief summary (registry, in English)

The objective of this study is to compare the frequency of post-thyroidectomy symptomatic and biochemical hypocalcaemia between the strategy of routine prophylactic calcium + calcitriol vs the administration of calcium guided by PTH values.

Status (registry)
Completed
Study type
Interventional
Enrollment
258 (actual)
First submitted
13 Feb 2022
Start date
30 Jun 2022
Primary completion date
30 Oct 2024
Lead sponsor
Centro de Excelencia en Enfermedades de Cabeza y Cuello
NCT number
NCT05252884

What you commit to

  • Study type: Interventional
  • Participants enrolled: 258
  • From 30 Jun 2022 to the primary completion date, 30 Oct 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • \- Patients with parathyroid surgery in conjunction with thyroidectomy, Patients with prior parathyroid disease for other causes (hyperparathyroidism primary or secondary to kidney disease, etc.), Patients with anaplastic carcinoma or lymphoma, Patients undergoing total thyroidectomy for causes other than thyroid disease such as, for example, total laryngectomy or pharyngo-laryngectomy that, due to margins or direct extension, require thyroidectomy. , Altered cognitive state that interfered or made the evaluation impossible.

Who the study is looking for

  • \- Patients undergoing total thyroidectomy who meet the following criteria: Patients over 18 years of age, Benign (goiter, thyroiditis, hyperthyroidism) or malignant (carcinoma) diagnosis, Patients who agree to participate in the study and sign the informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Alma Mater de Antioquia
Coordinator of this site? Confirm its status
MedellínColombiaUnknown status
Hospital Universitario San Vicente Fundacion
Coordinator of this site? Confirm its status
MedellínColombiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.